Sorry your story just just doesn’t make sense to me, if you read the company announcements, the company commencedinitiatives to lift the hold after receiving the FDA advice
17 January - Clinical hold
17 February - FDA Guidance on NUZ-001 IND Application
The Company has commenced initiatives to generate the additional exposure data and remains confident that further information will assist in reinforcing and better defining safety margins for NUZ-001’s clinical development…
not specify any safety concerns arising from previously undertaken clinical studies utilising NUZ-001.
NUZ Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)